151 related articles for article (PubMed ID: 21207370)
1. The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study.
Lanoy E; Spano JP; Bonnet F; Guiguet M; Boué F; Cadranel J; Carcelain G; Couderc LJ; Frange P; Girard PM; Oksenhendler E; Poizot-Martin I; Semaille C; Agut H; Katlama C; Costagliola D;
Int J Cancer; 2011 Jul; 129(2):467-75. PubMed ID: 21207370
[TBL] [Abstract][Full Text] [Related]
2. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
Int J Cancer; 2015 Nov; 137(10):2443-53. PubMed ID: 25976897
[TBL] [Abstract][Full Text] [Related]
3. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Costagliola D; Grabar S;
Clin Infect Dis; 2013 Dec; 57(11):1638-47. PubMed ID: 23899679
[TBL] [Abstract][Full Text] [Related]
4. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
6. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications.
Spano JP; Lanoy E; Mounier N; Katlama C; Costagliola D; Heard I
Eur J Cancer; 2012 Dec; 48(18):3335-41. PubMed ID: 22766516
[TBL] [Abstract][Full Text] [Related]
10. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
[TBL] [Abstract][Full Text] [Related]
11. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
12. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
[TBL] [Abstract][Full Text] [Related]
13. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
Herida M; Mary-Krause M; Kaphan R; Cadranel J; Poizot-Martin I; Rabaud C; Plaisance N; Tissot-Dupont H; Boue F; Lang JM; Costagliola D
J Clin Oncol; 2003 Sep; 21(18):3447-53. PubMed ID: 12972519
[TBL] [Abstract][Full Text] [Related]
14. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
[TBL] [Abstract][Full Text] [Related]
16. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
17. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.
Cooksley CD; Hwang LY; Waller DK; Ford CE
Int J STD AIDS; 1999 Dec; 10(12):795-802. PubMed ID: 10639060
[TBL] [Abstract][Full Text] [Related]
18. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals.
Busnach G; Piselli P; Arbustini E; Baccarani U; Burra P; Carrieri MP; Citterio F; De Juli E; Bellelli S; Pradier C; Rezza G; Serraino D;
Transplant Proc; 2006 Dec; 38(10):3533-5. PubMed ID: 17175324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
